Gross-Goupil M - Search Results

1

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.

Ladouceur A, Barnetche T, Mouterde G, Tison A, Bitoun S, Prey S, Dutriaux C, Gerard E, Pham-Ledard A, Beylot-Barry M, Zysman M, Veillon R, Domblides C, Daste A, Gross-Goupil M, Sionneau B, Lefort F, Larroquette M, Richez C, Truchetet ME, Schaeverbeke T, Kostine M. Ladouceur A, et al. RMD Open. 2023 Nov 29;9(4):e003795. doi: 10.1136/rmdopen-2023-003795. RMD Open. 2023. PMID: 38030233 Free PMC article.

2

Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.

Daste A, Gross-Goupil M, Roca S, Bernhard JC, Ravaud A. Daste A, et al. Target Oncol. 2014 Mar;9(1):81-4. doi: 10.1007/s11523-012-0245-6. Epub 2013 Jan 3. Target Oncol. 2014. PMID: 23283668 Review.

3

Optimal management of renal cell carcinoma in the elderly: a review.

Quivy A, Daste A, Harbaoui A, Duc S, Bernhard JC, Gross-Goupil M, Ravaud A. Quivy A, et al. Clin Interv Aging. 2013;8:433-42. doi: 10.2147/CIA.S30765. Epub 2013 Apr 19. Clin Interv Aging. 2013. PMID: 23626463 Free PMC article. Review.

4

Emerging antiangiogenics for renal cancer.

Domblides C, Gross-Goupil M, Quivy A, Ravaud A. Domblides C, et al. Expert Opin Emerg Drugs. 2013 Dec;18(4):495-511. doi: 10.1517/14728214.2013.858697. Expert Opin Emerg Drugs. 2013. PMID: 24274612 Review.

5

Protein kinase inhibitors in renal cell carcinoma.

Daste A, Grellety T, Gross-Goupil M, Ravaud A. Daste A, et al. Expert Opin Pharmacother. 2014 Feb;15(3):337-51. doi: 10.1517/14656566.2014.869210. Epub 2013 Dec 16. Expert Opin Pharmacother. 2014. PMID: 24328606 Review.

6

Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinoma.

Daste A, Gross-Goupil M, Ravaud A. Daste A, et al. Clin Genitourin Cancer. 2014 Jun;12(3):e115-6. doi: 10.1016/j.clgc.2014.01.003. Epub 2014 Jan 15. Clin Genitourin Cancer. 2014. PMID: 24524970 No abstract available.

7

Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature.

Daste A, Gross-Goupil M, Quivy A, François L, Bernhard JC, Ravaud A. Daste A, et al. Clin Genitourin Cancer. 2016 Oct;14(5):e525-e527. doi: 10.1016/j.clgc.2016.04.009. Epub 2016 Apr 22. Clin Genitourin Cancer. 2016. PMID: 27185091 Review. No abstract available.

8

Targeted therapy and elderly people: A review.

Daste A, Chakiba C, Domblides C, Gross-Goupil M, Quivy A, Ravaud A, Soubeyran P. Daste A, et al. Eur J Cancer. 2016 Dec;69:199-215. doi: 10.1016/j.ejca.2016.10.005. Epub 2016 Nov 15. Eur J Cancer. 2016. PMID: 27855351 Review.

9

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.

Teyssonneau D, Daste A, Dousset V, Hoepffner JL, Ravaud A, Gross-Goupil M. Teyssonneau D, et al. BMC Cancer. 2017 May 11;17(1):323. doi: 10.1186/s12885-017-3309-2. BMC Cancer. 2017. PMID: 28494780 Free PMC article.

10

Drug Interaction With Sunitinib and the Evidence of Therapeutic Drug Monitoring: A Case Report and Review of the Literature.

Bertolaso P, Gross-Goupil M, Molimard M, Cochin V, Ravaud A, Daste A. Bertolaso P, et al. Clin Genitourin Cancer. 2017 Oct;15(5):e885-e887. doi: 10.1016/j.clgc.2017.05.004. Epub 2017 May 10. Clin Genitourin Cancer. 2017. PMID: 28552572 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters